Prophylactic and therapeutic composition for MRSA infection

Details Prophylactic and therapeutic composition for MRSA infection Prophylactic and therapeutic composition for MRSA infection

1993-03-05

1995-06-06

Robinson, Douglas W.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

514 46, 514 47, 514 48, 514 49, 514 50, 514 51, A61K 3170

Patent

active

054223431

ABSTRACT:
The invention provides an anti-MRSA prophylactic/therapeutic composition containing as an active ingredient at least one nucleic acid component selected from among inosine, guanosine n'-monophosphate (GMP) (n'=2', 3'or 5'), uridine and thymidine.

REFERENCES:
patent: 4758553 (1988-07-01), Ogoshi
patent: 5231085 (1993-07-01), Alexander et al.
patent: 5246708 (1993-09-01), von Borstel et al.
patent: 5268365 (1993-12-01), Rudolph et al.
patent: 5320846 (1994-06-01), Bistrian et al.
J. Nutr. Sci. Vitaminol., 38, 22-225 (1992).
CA vol. 103, No. 24, 200878z.
CA vol. 113, No. 24, 217811b.

Affiliated with

Also associated with

Rating

Prophylactic and therapeutic composition for MRSA infection does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Prophylactic and therapeutic composition for MRSA infection, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prophylactic and therapeutic composition for MRSA infection will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-987814